Vanda Pharmaceuticals Profit Margin 2006-2021 | VNDA
Current and historical gross margin, operating margin and net profit margin for Vanda Pharmaceuticals (VNDA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Vanda Pharmaceuticals net profit margin as of September 30, 2021 is 12.77%.
|Vanda Pharmaceuticals Annual Profit Margins
|Vanda Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.